A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas
Clinical trial NCT03405454 · UNKNOWN
Trial details
- NCT number
- NCT03405454
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2021-09-15
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.